This episode is a snippet from the late 2023 Veterinary Pain Management Workshop hosted by IVDI, which offers a deep dive into nerve growth factor inhibitors, focuses on the cutting-edge therapeutic agents, Salencia for cats and Librella for dogs, addressing their mechanism and impact on pain management. Dr. Mark Epstein, a renowned pain management expert, shares insights from a 2023 workshop, breaking down complex mechanisms and their practical applications in clinical settings.
Main Talking Points:
- Introduction to Nerve Growth Factor (NGF) and its inhibitors.
- The biology and impact of NGF on pain pathways.
- Clinical use and observations with Silencia in cats and Labrella in dogs.
- Potential concerns and ongoing questions about NGF inhibitors.
- Co-administration with NSAIDs and its implications.
Interesting Quotes:
- “NGF is largely responsible for amplifying neurogenic inflammation, making it a prime target for therapeutic intervention.”
- “Silencia and Labrella offer significant improvements in mobility and quality of life for cats and dogs suffering from osteoarthritis.”
Timestamps:
- 0:00 – Introduction to the episode
- 1:30 – Speaker introduction: Dr. Mark Epstein
- 2:00 – Overview of nerve growth factor inhibitors
- 4:00 – The science behind NGF and pain management
- 6:00 – Clinical observations with Silencia and Labrella
- 8:00 – Addressing concerns and unanswered questions
- 9:30 – Discussion on co-administration with NSAIDs
Love Veterinary Dentistry?😍
The VDP Program is What You Have Been Looking For👇
https://ivdi.org/
This episode sheds light on the pivotal role of nerve growth factor inhibitors in managing chronic pain in pets. Dr. Mark Epstein’s expertise offers a comprehensive understanding of how these inhibitors work, their clinical benefits, and the nuanced considerations in their application.
Podcast: Play in new window | Download